Analysis of commercial and public bioactivity databases

Pekka Tiikkainen1, Lutz Franke

  • 1Merz Pharmaceuticals GmbH, Eckenheimer Landstrasse 100, 60318 Frankfurt am Main, Germany. pekka.tiikkainen@merz.de

Summary

Merging public and commercial bioactivity databases created a unified resource. Despite common inconsistencies, each database offers unique small molecule activity data, making diverse data sources valuable for chemoinformatics research.